Nebenwirkungen · Bondronat
Bondronat 50 mg film-coated tablets. · Abschnitt 4.8 · PDF-Seite 20
HOS-085667 · Präparat HOS-083171
System Organ Common Uncommon Rare Very rare Not known Class Blood and Anaemia lymphatic system disorders Immune system Hypersensitivity†, Asthma disorders bronchospasm†, exacerbation angioedema†, Anaphylactic reaction/shock†** Metabolism and Hypocalcaemia** nutrition disorders Nervous system Paraesthesia, disorders dysgeusia (taste perversion) Eye disorders Ocular inflammation†** Gastrointestinal Oesophagitis, Haemorrage, disorders abdominal pain, duodenal dyspepsia, nausea ulcer, gastritis, dysphagia, dry mouth Skin and Pruritus Stevens-Johnson subcutaneous Syndrome†, tissue disorders Erythema Multiforme†, Dermatitis Bullous† Musculoskeletal Atypical Osteonecrosis of Atypical and connective subtrochanteric jaw†** fractures of tissue disorders and diaphyseal Osteonecrosis of long bones femoral the external other than the fractures† auditory canal femur (bisphosphonate class adverse reaction)† Renal and Azotaemia urinary (uraemia) disorders General Asthenia Chest pain, disorders and influenza-like administration site conditions illness, malaise, pain Investigations Blood parathyroid hormone increased **See further information below †Identified in post-marketing experience.
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2024-04-08T17:34:00Z · SHA-256 05636f81465a8a67f982eee4655be333acd7e9f5a20c04764f8127645519a0a1 · Passage 12db2a1e8412b83f21dfc20561ea9daa4a8a3448dfe897b8dcc8e3bdaa0e7bb4 · Zeichen 1311–4343 im Abschnitt